HomeCompareBIOGY vs MO

BIOGY vs MO: Dividend Comparison 2026

BIOGY yields 6.44% · MO yields 9.11%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BIOGY wins by $26810.95M in total portfolio value
10 years
BIOGY
BIOGY
● Live price
6.44%
Share price
$11.00
Annual div
$0.71
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26810.97M
Annual income
$26,033,859,346.54
Full BIOGY calculator →
MO
Altria Group Inc.
● Live price
9.11%
Share price
$44.80
Annual div
$4.08
5Y div CAGR
4.3%
Payout ratio
78%
After 10 yrs · $10,000 · DRIP
Portfolio value
$27.7K
Annual income
$4,052.72
Full MO calculator →

Portfolio growth — BIOGY vs MO

📍 BIOGY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBIOGYMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BIOGY + MO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BIOGY pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BIOGY
Annual income on $10K today (after 15% tax)
$547.03/yr
After 10yr DRIP, annual income (after tax)
$22,128,780,444.56/yr
MO
Annual income on $10K today (after 15% tax)
$774.11/yr
After 10yr DRIP, annual income (after tax)
$3,444.81/yr
At 15% tax rate, BIOGY beats the other by $22,128,776,999.75/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BIOGY + MO for your $10,000?

BIOGY: 50%MO: 50%
100% MO50/50100% BIOGY
Portfolio after 10yr
$13405.50M
Annual income
$13,016,931,699.63/yr
Blended yield
97.10%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

BIOGY
No analyst data
Altman Z
24.5
Piotroski
5/9
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
+36.7% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BIOGY buys
0
MO buys
0
No recent congressional trades found for BIOGY or MO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBIOGYMO
Forward yield6.44%9.11%
Annual dividend / share$0.71$4.08
Payout ratio50%78%
1-year div growth0%4.1%
5-year div CAGR100%4.3%
Portfolio after 10y$26810.97M$27.7K
Annual income after 10y$26,033,859,346.54$4,052.72
Total dividends collected$26757.34M$20.9K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: BIOGY vs MO ($10,000, DRIP)

YearBIOGY PortfolioBIOGY Income/yrMO PortfolioMO Income/yrGap
1← crossover$11,987$1,287.13$10,740$949.88+$1.2KBIOGY
2$15,710$2,883.92$11,601$1,086.84+$4.1KBIOGY
3$23,875$7,064.71$12,608$1,250.75+$11.3KBIOGY
4$45,613$20,067.60$13,792$1,448.20+$31.8KBIOGY
5$120,470$71,663.60$15,190$1,687.69+$105.3KBIOGY
6$482,681$353,778.32$16,851$1,980.28+$465.8KBIOGY
7$3,165,940$2,649,470.74$18,838$2,340.48+$3.15MBIOGY
8$35,869,920$32,482,364.61$21,230$2,787.44+$35.85MBIOGY
9$726,275,008$687,894,193.55$24,130$3,346.72+$726.25MBIOGY
10$26,810,973,605$26,033,859,346.54$27,676$4,052.72+$26810.95MBIOGY

BIOGY vs MO: Complete Analysis 2026

BIOGYStock

BioGaia AB (publ) develops, markets, and sells probiotic products with documented health benefits worldwide. It operates through three segments: Pediatrics, Adult Health, and Other. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. The company offers its products in the areas of infantile colic and digestive health in children; antibiotic-associated and acute diarrhoea; gingivitis; periodontal disease; general health; Helicobacter pylori–the gastric ulcer bacterium; and low bone density. It offers its products under the BioGaia brand name. BioGaia AB (publ) was founded in 1990 and is headquartered in Stockholm, Sweden.

Full BIOGY Calculator →

MOConsumer Staples

Altria is a Dividend King with 54+ consecutive years of dividend increases — one of the longest streaks in American corporate history. While cigarette volumes decline, pricing power and new product categories (oral nicotine pouches via NJOY) support cash flows. The near-9% yield is among the highest in the S&P 500.

Full MO Calculator →
📬

Get this BIOGY vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BIOGY vs SCHDBIOGY vs JEPIBIOGY vs OBIOGY vs KOBIOGY vs MAINBIOGY vs PMBIOGY vs BTIBIOGY vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.